Explain the Latest Guidance for Gout Management

You’ll get questions about managing patients with gout...due to updated guidelines.

Chronic gout. Last year, FDA warned about febuxostat increasing CV death compared to allopurinol. Now guidelines are catching up with the evidence.

Consider stopping febuxostat if a patient taking it is admitted with an MI, stroke, or other CV event.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals